Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Hope for rapid equine influenza test
“Preventing a new influenza pandemic requires both vaccination and antiviral drugs to be administered within 48 hours of the infection."
Scientists say dipstick test could offer results in seconds 

A simple dipstick test could offer a rapid, non-invasive method of screening for equine influenza.

Iceni Diagnostics has a patent for its approach to detecting and distinguishing between human and avian flu. The company believes that with a slight modification, the test could be used for routine screening in horses before they travel to race meets and other gatherings.

Professor Robert Field, co-founder at Iceni, said 90 per cent of infections use carbohydrate recognition to bind with targets in humans and animals. This mechanism is specific to each strain of flu, so it can be used as a sensor for the disease.

“Our sensor uses sugars tagged with inexpensive gold nanoparticles,” he explained. “If the virus is present it will stick to the particles, pulling them closer together. This creates a photophysics reaction and the sample changes colour.

“We have found that there are differences between the carbohydrate detectors in the different types of flu. It is therefore possible to use a colour change to identify presence and absence of the virus and to distinguish between them.”

Using sugars instead of more commonly used protein-based diagnostics avoids the need for cold storage, meaning the test can be used worldwide with minimal training, and gives results in seconds.

According to Professor David Russell, chief scientist at Iceni, the new assay based on gold nanoparticles is much faster than current tests.

“Preventing a new influenza pandemic requires both vaccination and antiviral drugs to be administered within 48 hours of the infection in order to contain the disease,” he said.

“Current methods of detection require isolation and culturing of the virus, which may take several hours or even days to get the results. Using our test it would be possible to quickly identify infected animals at the stables and quarantine them, preventing the spread of disease.”

Iceni is now looking for investment to modify its sensor to produce a dip test for equine flu.

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
BBC Radio 4 documentary addresses corporate fees

BBC Radio 4's File on 4 Investigates has released a documentary exploring how corporate-owned veterinary practices may be inflating bills to increase profit.

Released on 15 April, 'What's Happening To Your Vet Bills?' revealed the policies which many corporate groups have in place to increase their profits. This included targets and upgrades which veterinary teams are tasked with meeting on a regular basis.

It also features Anrich Vets, an independently-owned practice based in Wigan. Following the case of Staffordshire terrier Benjy, who is diagnosed with a tumour, the documentary shares how the team were able to offer contextualised care and advice to make the procedure as affordable as possible for his owners.

The documentary can be heard on demand on BBC iPlayer.